Bettina Lundgren is CEO of the Danish National Genome Center. The Danish National Genome Center supports physicians and researchers in using knowledge on patients’ genes and new technology to develop personalized medicine. CEO Lundgren leads the further development of the center, where emphasis is placed on the center’s work to benefit the individual patient and to promote international and national research in personal medicine in the Danish healthcare system.
CEO Lundgren is a specialist in Clinical Microbiology and a Doctor of Medicine from the University of Copenhagen. Since 2010, she has been center director for more than 1,600 employees at the Diagnostic Center at Rigshospitalet. CEO Lundgren has in-depth knowledge of the Danish healthcare system and extensive experience from several clinical departments. She has more than 19 years of management experience from the health service as well as broad research experience from several employments both at home and abroad, including the US National Institutes of Health (NIH).